Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Wink LK, Minshawi NF, Shaffer RC, Plawecki MH, Posey DJ, Horn PS, Adams R, Pedapati EV, Schaefer TL, McDougle CJ, Swiezy NB, Erickson CA.

Mol Autism. 2017 Jan 25;8:2. doi: 10.1186/s13229-017-0116-1. eCollection 2017.

2.

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA.

Mol Autism. 2016 Apr 21;7:26. doi: 10.1186/s13229-016-0088-6. eCollection 2016.

3.

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders.

Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, Hurwitz S, McDougle CJ, Swiezy NB, Erickson CA.

Mol Autism. 2016 Jan 14;7:2. doi: 10.1186/s13229-015-0062-8. eCollection 2016.

4.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

5.

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL.

Pharmacogenomics J. 2014 Jun;14(3):295-302. doi: 10.1038/tpj.2013.23. Epub 2013 Jul 16.

6.

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.

Nurmi EL, Spilman SL, Whelan F, Scahill LL, Aman MG, McDougle CJ, Arnold LE, Handen B, Johnson C, Sukhodolsky DG, Posey DJ, Lecavalier L, Stigler KA, Ritz L, Tierney E, Vitiello B, McCracken JT; Research Units on Pediatric Psychopharmacology Autism Network.

Transl Psychiatry. 2013 Jun 25;3:e274. doi: 10.1038/tp.2013.26.

7.

The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Ho JG, Caldwell RL, McDougle CJ, Orsagh-Yentis DK, Erickson CA, Posey DJ, Stigler KA.

J Child Adolesc Psychopharmacol. 2012 Aug;22(4):277-83. doi: 10.1089/cap.2011.0129. Epub 2012 Jul 31.

8.

Individual common variants exert weak effects on the risk for autism spectrum disorders.

Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Casey J, Conroy J, Correia C, Corsello C, Crawford EL, de Jonge M, Delorme R, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Gilbert J, Gillberg C, Glessner JT, Green A, Green J, Guter SJ, Heron EA, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Jacob S, Kenny GP, Kim C, Kolevzon A, Kustanovich V, Lajonchere CM, Lamb JA, Law-Smith M, Leboyer M, Le Couteur A, Leventhal BL, Liu XQ, Lombard F, Lord C, Lotspeich L, Lund SC, Magalhaes TR, Mantoulan C, McDougle CJ, Melhem NM, Merikangas A, Minshew NJ, Mirza GK, Munson J, Noakes C, Nygren G, Papanikolaou K, Pagnamenta AT, Parrini B, Paton T, Pickles A, Posey DJ, Poustka F, Ragoussis J, Regan R, Roberts W, Roeder K, Roge B, Rutter ML, Schlitt S, Shah N, Sheffield VC, Soorya L, Sousa I, Stoppioni V, Sykes N, Tancredi R, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Vorstman JA, Wallace S, Wing K, Wittemeyer K, Wood S, Zurawiecki D, Zwaigenbaum L, Bailey AJ, Battaglia A, Cantor RM, Coon H, Cuccaro ML, Dawson G, Ennis S, Freitag CM, Geschwind DH, Haines JL, Klauck SM, McMahon WM, Maestrini E, Miller J, Monaco AP, Nelson SF, Nurnberger JI Jr, Oliveira G, Parr JR, Pericak-Vance MA, Piven J, Schellenberg GD, Scherer SW, Vicente AM, Wassink TH, Wijsman EM, Betancur C, Buxbaum JD, Cook EH, Gallagher L, Gill M, Hallmayer J, Paterson AD, Sutcliffe JS, Szatmari P, Vieland VJ, Hakonarson H, Devlin B.

Hum Mol Genet. 2012 Nov 1;21(21):4781-92. doi: 10.1093/hmg/dds301. Epub 2012 Jul 26.

9.

Paliperidone for irritability in adolescents and young adults with autistic disorder.

Stigler KA, Mullett JE, Erickson CA, Posey DJ, McDougle CJ.

Psychopharmacology (Berl). 2012 Sep;223(2):237-45. doi: 10.1007/s00213-012-2711-3. Epub 2012 May 3.

PMID:
22549762
10.

A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder.

Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R, Shields DC, Abrahams BS, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolton PF, Bourgeron T, Brennan S, Cali P, Correia C, Corsello C, Coutanche M, Dawson G, de Jonge M, Delorme R, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Foley S, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Green J, Guter SJ, Hakonarson H, Holt R, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Lamb JA, Leboyer M, Le Couteur A, Leventhal BL, Lord C, Lund SC, Maestrini E, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Miller J, Minopoli F, Mirza GK, Munson J, Nelson SF, Nygren G, Oliveira G, Pagnamenta AT, Papanikolaou K, Parr JR, Parrini B, Pickles A, Pinto D, Piven J, Posey DJ, Poustka A, Poustka F, Ragoussis J, Roge B, Rutter ML, Sequeira AF, Soorya L, Sousa I, Sykes N, Stoppioni V, Tancredi R, Tauber M, Thompson AP, Thomson S, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Vorstman JA, Wallace S, Wang K, Wassink TH, White K, Wing K, Wittemeyer K, Yaspan BL, Zwaigenbaum L, Betancur C, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Geschwind DH, Haines JL, Hallmayer J, Monaco AP, Nurnberger JI Jr, Pericak-Vance MA, Schellenberg GD, Scherer SW, Sutcliffe JS, Szatmari P, Vieland VJ, Wijsman EM, Green A, Gill M, Gallagher L, Vicente A, Ennis S.

Hum Genet. 2012 Apr;131(4):565-79. doi: 10.1007/s00439-011-1094-6. Epub 2011 Oct 14.

11.

Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.

Bernhardt EB, Walsh KH, Posey DJ, McDougle CJ.

J Clin Psychopharmacol. 2011 Oct;31(5):673-5. doi: 10.1097/JCP.0b013e31822c92d4. No abstract available.

PMID:
21881459
12.

Guanfacine extended release in two patients with pervasive developmental disorders.

Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2011 Jun;21(3):287-90. doi: 10.1089/cap.2010.0057. No abstract available.

13.

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ.

Ped Health. 2010 Sep 29;4(4):375-381.

14.

A prospective open-label study of aripiprazole in fragile X syndrome.

Erickson CA, Stigler KA, Wink LK, Mullett JE, Kohn A, Posey DJ, McDougle CJ.

Psychopharmacology (Berl). 2011 Jul;216(1):85-90. doi: 10.1007/s00213-011-2194-7. Epub 2011 Feb 12.

PMID:
21318565
15.

A genome-wide scan for common alleles affecting risk for autism.

Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Carson AR, Casallo G, Casey J, Chu SH, Cochrane L, Corsello C, Crawford EL, Crossett A, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Melhem NM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Piven J, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Wing K, Wittemeyer K, Wood S, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Betancur C, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Gallagher L, Geschwind DH, Gill M, Haines JL, Miller J, Monaco AP, Nurnberger JI Jr, Paterson AD, Pericak-Vance MA, Schellenberg GD, Scherer SW, Sutcliffe JS, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Devlin B, Ennis S, Hallmayer J.

Hum Mol Genet. 2010 Oct 15;19(20):4072-82. doi: 10.1093/hmg/ddq307. Epub 2010 Jul 27.

16.

Aripiprazole in autism spectrum disorders and fragile X syndrome.

Erickson CA, Stigler KA, Posey DJ, McDougle CJ.

Neurotherapeutics. 2010 Jul;7(3):258-63. doi: 10.1016/j.nurt.2010.04.001. Review.

17.

Functional impact of global rare copy number variation in autism spectrum disorders.

Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL, Hallmayer J, Miller J, Monaco AP, Nurnberger JI Jr, Paterson AD, Pericak-Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C.

Nature. 2010 Jul 15;466(7304):368-72. doi: 10.1038/nature09146. Epub 2010 Jun 9.

18.

Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.

Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB.

J Child Adolesc Psychopharmacol. 2010 Apr;20(2):83-93. doi: 10.1089/cap.2009.0022.

19.

Paliperidone for irritability in autistic disorder.

Stigler KA, Erickson CA, Mullett JE, Posey DJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2010 Feb;20(1):75-8. doi: 10.1089/cap.2009.0019. No abstract available.

PMID:
20166801
20.

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Stigler KA, Diener JT, Kohn AE, Li L, Erickson CA, Posey DJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):265-74. doi: 10.1089/cap.2008.093.

21.

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.

Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H.

Nature. 2009 May 28;459(7246):569-73. doi: 10.1038/nature07953. Epub 2009 Apr 28.

22.

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L.

J Autism Dev Disord. 2009 Mar;39(3):405-13. doi: 10.1007/s10803-008-0637-8. Epub 2008 Sep 13.

PMID:
18791817
23.

Developing drugs for core social and communication impairment in autism.

Posey DJ, Erickson CA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):787-801, viii-ix. doi: 10.1016/j.chc.2008.06.010. Review.

24.

Treating autism spectrum disorders. Preface.

Posey DJ, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):xv-xviii. doi: 10.1016/j.chc.2008.07.001. No abstract available.

PMID:
18775365
25.

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.

Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ.

J Autism Dev Disord. 2009 Mar;39(3):395-404. doi: 10.1007/s10803-008-0636-9. Epub 2008 Aug 28.

26.

Cognitive effects of risperidone in children with autism and irritable behavior.

Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, Posey DJ.

J Child Adolesc Psychopharmacol. 2008 Jun;18(3):227-36. doi: 10.1089/cap.2007.0133.

27.

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

McDougle CJ, Stigler KA, Erickson CA, Posey DJ.

J Clin Psychiatry. 2008;69 Suppl 4:15-20. Review.

28.

Antipsychotics in the treatment of autism.

Posey DJ, Stigler KA, Erickson CA, McDougle CJ.

J Clin Invest. 2008 Jan;118(1):6-14. doi: 10.1172/JCI32483. Review.

29.

Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.

Posey DJ, McDougle CJ.

CNS Drug Rev. 2007 Winter;13(4):465-74. Review.

30.

Pharmacologic treatment of autism and related disorders.

Erickson CA, Posey DJ, Stigler KA, McDougle CJ.

Pediatr Ann. 2007 Sep;36(9):575-85. Review. No abstract available.

PMID:
17910205
31.

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.

Biol Psychiatry. 2007 Feb 15;61(4):538-44.

PMID:
17276750
32.

Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.

Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D.

J Intellect Dev Disabil. 2006 Dec;31(4):204-9.

PMID:
17178532
33.

Ramelteon for insomnia in two youths with autistic disorder.

Stigler KA, Posey DJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):631-6.

PMID:
17069551
34.

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):599-610.

PMID:
17069548
35.

A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ.

Psychopharmacology (Berl). 2007 Mar;191(1):141-7. Epub 2006 Oct 3.

PMID:
17016714
36.

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, Ritz L, Swiezy NB, Vitiello B; Research Units on Pediatric Psychopharmacology Autism Network.

J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1114-23.

PMID:
16926619
37.

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B.

Biol Psychiatry. 2007 Feb 15;61(4):545-50. Epub 2006 May 30.

PMID:
16730335
38.

Risperidone and adaptive behavior in children with autism.

Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, Cicchetti D, Sparrow S.

J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):431-9.

PMID:
16601648
39.

Validity of the autism diagnostic interview-revised.

Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, Lee LS, Kau AS.

Am J Ment Retard. 2006 May;111(3):199-215.

PMID:
16597187
40.

The use of selective serotonin reuptake inhibitors in autism and related disorders.

Posey DJ, Erickson CA, Stigler KA, McDougle CJ.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):181-6. Review.

PMID:
16553538
41.

Neurochemistry in the pathophysiology of autism.

McDougle CJ, Erickson CA, Stigler KA, Posey DJ.

J Clin Psychiatry. 2005;66 Suppl 10:9-18. Review.

42.

Acute and long-term safety and tolerability of risperidone in children with autism.

Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL.

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84.

PMID:
16379507
43.

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.

Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L, Tierney E, Posey DJ, Swiezy NB, Koenig K.

J Clin Psychopharmacol. 2005 Dec;25(6):565-9.

PMID:
16282839
44.

Risperidone in pervasive developmental disorders.

Erickson CA, Stigler KA, Posey DJ, McDougle CJ.

Expert Rev Neurother. 2005 Nov;5(6):713-9. Review.

PMID:
16274329
45.

Gastrointestinal factors in autistic disorder: a critical review.

Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ.

J Autism Dev Disord. 2005 Dec;35(6):713-27. Review.

PMID:
16267642
46.

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B.

Am J Psychiatry. 2005 Jun;162(6):1142-8.

PMID:
15930063
47.

Intramuscular ziprasidone for acute agitation in adolescents.

Hazaray E, Ehret J, Posey DJ, Petti TA, McDougle CJ.

J Child Adolesc Psychopharmacol. 2004 Fall;14(3):464-70.

PMID:
15650504
48.

Aripiprazole for maladaptive behavior in pervasive developmental disorders.

Stigler KA, Posey DJ, McDougle CJ.

J Child Adolesc Psychopharmacol. 2004 Fall;14(3):455-63.

PMID:
15650503
49.

Brief report: autistic disorder in three children with cytomegalovirus infection.

Sweeten TL, Posey DJ, McDougle CJ.

J Autism Dev Disord. 2004 Oct;34(5):583-6.

PMID:
15628611
50.

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

Corson AH, Barkenbus JE, Posey DJ, Stigler KA, McDougle CJ.

J Clin Psychiatry. 2004 Nov;65(11):1531-6.

PMID:
15554768

Supplemental Content

Loading ...
Support Center